LEGAL DISCLAIMER Please note everything discussed at this site is a personal opinion of the author and may contain errors or omissions. NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT. It would be your sole responsibility for actions you undertake as a consequence of any analysis, opinion or advertisement on this site.
Total Pageviews
Saturday, June 14, 2014
Don't follow the crowd
As I have talked many times, when there is panic with a
feeling of blood in the street, there is likely a great opportunity that you
may find some gems to pick up. This is so-called contrarian investment. You go
against what all the other people [the herd, including those Wall Street (WS)
analysts] are doing and act lonely at that time. More often than not, you will
be the winner, not the herd! Let’s use an example I talked about here to
illustrate this. A few years ago there was a major sell-off for Genzym,
a very successful biotech company specialized in orphan drugs for rare
diseases. The reason for the bloodshed for Genzym was that it had some
recurring quality issues identified for some batches of its products
and the FDA issued a warning for it. People got nervous and all were rushing to
dump it, cutting the stock price almost by half. This is a typical WS
herd behavior that they tend to sell first before asking. When I saw this, I
became very interested in the stock and wanted to know what was going wrong
with it. It turned out this was nothing fundamental at all but just some
temporary issues that all the companies could run into at some point. I was
pretty sure that the company would fix the problem and all the business would return
to normal before long. Actually what was more unique to this problem with
Genzym was that even the FDA acknowledged that there was no replacement for the
product of interest and advised patients not to discontinue the treatment,
since this was an orphan drug only Genzym was producing. So what was the
concern? To me it was more of a psychological concern than anything material
and it was a great contrarian buy for Genzym. Yes, I did so when Genzym was around $50. Guess what happened to the company?
It was bought up by Sanofi in less than a year with a price tag over
$70 per share!! The lesson? Find gems during a crisis. I hope my blog may help
you to target something interesting to you and I think I find another one. Stay
tuned.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment